Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -32.33%. However, over the last six months, the performance has been stronger by -32.84%. The price of NUVB decreased -19.64% over the last 30 days. And in the last five days, it has fallen by -28.29%.
Nuvation Bio Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $3.97 on 07/31/24, while the lowest price for the same period was registered at $1.54 on 04/07/25.
52-week price history of NUVB Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Nuvation Bio Inc’s current trading price is -54.66% away from its 52-week high, while its distance from the 52-week low is 16.88%. The stock’s price range during this period has varied between$1.54 and $3.97. The Nuvation Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 5.34 million for the day, a figure considerably higher than their average daily volume of 4.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Nuvation Bio Inc (NUVB) has experienced a quarterly decline of -13.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 612.47M and boasts a workforce of 220 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
NUVB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
